Aspects of Insulin Treatment in Uremic Insulin-Dependent Diabetic Patients before and after Active Replacement Therapy
Since intensive metabolic control and vigorous antihypertensive therapy only postpone, but do not prevent, end-stage renal failure (ESRF) in diabetics and because diabetics in many parts of the world are no longer excluded from ESRF programs, it is not surprising that a great and still increasing number of candidates for dialysis therapy and kidney transplantation consist of diabetic patients. At the moment 10%–25% of the population admitted to ESRF programs in the United States and Western Europe suffer from diabetes mellitus. Consequently, profound insight into the pathophysiology of glucose homeostasis and insulin kinetics in this complicated clinical condition is necessary to assure optimal therapy in nondialyzed, dialyzed, and recently kidney-transplanted diabetic patients. A perfect glycemic and metabolic control is obviously still the goal of therapy in these diabetics in order to reduce further morbidity in a group of patients already heavily burdened by severe complications.
KeywordsDiabetic Nephropathy Continuous Ambulatory Peritoneal Dialysis Continuous Subcutaneous Insulin Infusion Dialysis Therapy Normal Kidney Function
Unable to display preview. Download preview PDF.
- 5.Schmitz O, Arnfred J, Orskov C, Nielsen OH: Uremia is characterized by impaired glucose-mediated glucose uptake and inappropriate hepatic glucose output to a.hyperglycemic challenge. (Submitted for publication), 1987.Google Scholar
- 11.Schmitz O, Alberti KGMM, Orskov H: Insulin resistance in uraemic insulin-dependent diabetics: effect of dialysis therapy as assessed by the artificial endocrine pancreas. Acta Endocrinol (Copenh) 105: 371–378, 1984.Google Scholar
- 20.Hansen AaP, Orskov H, Hansen HE, Schmitz O, Posborg V, Nosadini GA, Noy GA, Alberti KGMM: Glucose control during hemodialysis of diabetic patients. J Artif Organs ISuppl] 5: 681–685, 1981.Google Scholar
- 22.Schade DS, Eaton RP, Friedman NM, Spencer WJ: Normalization of plasma insulin profiles with intraperitoneal insulin infusion in diabetic man. Diabetologia 19:35,-39, 1980.Google Scholar
- 24.Janle-Swain E, Thornhill JA, Carter JM, Hinsman I, Jackson H, Swain SL, Ash SR: Improvement in kidney function with continuous intraperitoneal insulin infusion (CIPII) in severe diabetic glomerulopathy. Diabetic Nephropathy 2: 16–22, 1983.Google Scholar
- 25.Stephen RL, Maxwell JG, Kablitz C, Jacobsen SC, Hanover B, Tyler F: Intraperitoneal insulin regimens and diabetic nephropathy. In: Davison AM, Guillou PJ (eds) Proceedings of the European Dialysis and Transplant Association-European Renal Association, vol 20. London: Pitman, 1983, pp 692–699.Google Scholar
- 26.Johnson CA, Amidon G, Reichert JE, Porter WR: Absorption of insulin to the surface of peritoneal dialysis solution containers. Am J Kidnery Dis 3: 224–228, 1983.Google Scholar
- 28.Rottembourg J, Issad B, Poignet JL, Strippoli P, Balducci A, Slama G, Gahl GM: Residual renal function and control of blood glucose levels in insulin-dependent diabetic patients treated by CAPD. In: Keen H, Legrain M (eds) Prevention and treatment of diabetic nephropathy. Lancaster UK: MTP Press, 1983, pp 339–352.Google Scholar
- 29.Schmitz O, Sorensen SS, Alberti KGMM, Orskov H, Hansen HE: Metabolic control in newly kidney transplanted type 1 diabetics: ‘normalization’ by insulin pump treatment (CSII). J Diabetic Complications (in press), 1987.Google Scholar